BMC cancer
Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy.
Khadija Arif, Maryam Yousaf, Dilawar Khan
Published: 202510.1186/s12885-025-15214-5
No abstract available for this study.